Advanced searches left 3/3
Search only database of 12 mil and more summaries

Complete Rebate Humira

Summarized by PlexPage
Last Updated: 18 January 2022

* If you want to update the article please login/register

General | Latest Info

You should not taking HUMIRA if you have any kind of infection unless your doctor says it is okay. Serious infections have happened people taking HUMIRA. These serious infections include tuberculosis and infections caused by viruses, fungi, or bacteria that have spread throughout body. Some people died from these infections. Your doctor should test you for TB before starting HUMIRA, and check you closely for signs and symptoms of during treatment with HUMIRA, even if your TB test was negative. If your doctor feels you are at risk, you be treated with medicine for TB. What is most important information I should know about HUMIRA? You should discuss benefits and risks of HUMIRA with your doctor. Humira is TNF blocker medicine that can lower ability of your immune system to fight infections. You should not start taking HUMIRA if you have any kind of infection unless your doctor it is okay. Serious infections have in people taking HUMIRA. These serious infections include tuberculosis and infections caused by viruses, fungi, or bacteria that have spread throughout body. Some people have from these infections. Your doctor should test you TB before starting HUMIRA, and check you closely for signs and symptoms of TB during treatment with HUMIRA, even if your TB test was negative. If your doctor feels you are at risk, you may treated with medicine for TB. Cancer. For children and adults taking TNF blockers, HUMIRA, chance of getting lymphoma or other cancers may increase. There have cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed rare type of cancer called hepatosplenic T - cell lymphoma. This type cancer often results in death. If using TNF blockers, including HUMIRA, your chance of getting two types of cancer may increase. These types are generally not life - threatening if treat; tell your doctor if you have bump or open sore that wo heal. Tell your doctor about all of health conditions, including if you: have infection, are being treated for infection, or have symptoms of infection. Get lot of infections infections that keep coming back. Have diabetes, have TB or have been in close contact with someone with TB, or were born in, live in, or travel where there is more risk of getting TB Live or have lived in area where is increased risk of getting certain kinds of fungal infections, such AS histoplasmosis, coccidioidomycosis, or blastomycosis. These infections happen or become more severe if you use HUMIRA. Ask your doctor if you are unsure if you have lived these areas. Have or have had hepatitis B are scheduled for major surgery Have or have had cancer have numbness or tingling or nervous system disease such multiple sclerosis or Guillain - Barre syndrome Have or had heart failure Have recently received or are scheduled to receive vaccine.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

INDICATIONS 1

Rheumatoid Arthritis: HUMIRA is indicate, alone or in combination with methotrexate or other nonbiologic DMARDs, for reducing signs and symptoms, inducing major response, inhibiting progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid Arthritis. Juvenile Idiopathic Arthritis: HUMIRA is indicate, alone or in combination with methotrexate, for reducing signs and symptoms of moderately to severely active polyarticular juvenile Idiopathic Arthritis patients 2 years of age and older. Psoriatic Arthritis: HUMIRA is alone or in combination with nonbiologic DMARDs, for reducing signs and symptoms, inhibiting progression of structural damage, and improving physical function in adult patients with active psoriatic Arthritis. Ankylosing Spondylitis: HUMIRA is indicated reducing signs and symptoms in adult patients with active ankylosing Spondylitis. Adult Crohn's Disease: HUMIRA is indicated for reducing and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn's Disease who have had inadequate response to conventional therapy, and reducing signs and symptoms and inducing clinical remission in these patients if they have also lose response to or are intolerant to infliximab. Pediatric Crohn's Disease: HUMIRA is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients 6 years of age and older with moderately to severely active Crohn's Disease who have had inadequate response to corticosteroids or immunomodulators such azathioprine, 6mercaptopurine, or methotrexate. Ulcerative Colitis: HUMIRA is indicated for inducing and sustaining clinical remission in adult patients with moderately to severely active ulcerative who have had inadequate response to immunosuppressants such AS corticosteroids, azathioprine, or 6mercaptopurine. Effectiveness Of HUMIRA Has Not Been Established In Patients Who Have Lost Response To Or Were Intolerant To AntiTNF Agents. Plaque Psoriasis: HUMIRA is indicated for treatment of adult patients with moderate to severe chronic plaque Psoriasis who candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. Humira should only be administered to patients who will be monitored and have regular followup visits with physician. Hidradenitis Suppurativa: HUMIRA is indicated for treatment of moderate to severe hidradenitis Suppurativa in patients 12 of age and older.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

INDICATION 1

Rheumatoid Arthritis: HUMIRA is indicate, alone or in combination with methotrexate or non - biologic DMARDs, for reducing signs and symptoms, inducing major clinical response, inhibiting progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid Arthritis. Juvenile Idiopathic HUMIRA is indicate, alone or in combination with methotrexate, for reducing signs and symptoms of moderately to severely active polyarticular juvenile Idiopathic Arthritis in patients 2 years of age and older. Psoriatic Arthritis: HUMIRA is indicate, alone or in combination with non - biologic DMARDs, for reducing signs symptoms, inhibiting progression of structural damage, and improving physical function in adult patients with active psoriatic Arthritis. Ankylosing Spondylitis: HUMIRA is indicated to reducing signs and symptoms in adult patients with ankylosing Spondylitis. Adult Crohn's Disease: HUMIRA is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn's Disease who have had inadequate response to conventional therapy, and reducing signs symptoms and inducing clinical remission in these patients if they have also lose response to or are intolerant to infliximab. Pediatric Crohn's Disease: HUMIRA is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients 6 years of and older with moderately to severely active Crohn's Disease who have had inadequate response to corticosteroids or immunomodulators such AS azathioprine, 6 - mercaptopurine, or methotrexate. Ulcerative Colitis: HUMIRA is indicated for inducing and sustaining clinical remission in adult patients with moderately to severely active ulcerative Colitis who have had inadequate response to such AS corticosteroids, azathioprine, or 6 - mercaptopurine. Effectiveness Of HUMIRA Has Not Been Established In Patients Who Have Lost Response To Or Were Intolerant To Anti - TNF Agents. Plaque Psoriasis: HUMIRA is indicated for treatment of adult patients with moderate to severe chronic plaque who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. Humira should only be administered to patients will be closely monitored and have regular follow - up visits with physician. Hidradenitis Suppurativa: HUMIRA is indicated for treatment of moderate to severe hidradenitis Suppurativa in patients years of age and older. Humira is indicate, alone or in combination with or other non - biologic DMARDs, for reducing signs and symptoms, inducing major clinical response, inhibiting progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid Arthritis.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Sources

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

logo

Plex.page is an Online Knowledge, where all the summaries are written by a machine. We aim to collect all the knowledge the World Wide Web has to offer.

Partners:
Nvidia inception logo

© All rights reserved
2022 made by Algoritmi Vision Inc.

If you believe that any of the summaries on our website lead to misinformation, don't hesitate to contact us. We will immediately review it and remove the summaries if necessary.

If your domain is listed as one of the sources on any summary, you can consider participating in the "Online Knowledge" program, if you want to proceed, please follow these instructions to apply.
However, if you still want us to remove all links leading to your domain from Plex.page and never use your website as a source, please follow these instructions.